Here are some of the companies saying weight loss drugs could impact their business
[ad_1] The impact of new weight loss treatments is being felt well beyond the health-care industry . Analysts used the ritual of quarterly earnings calls to probe companies on whether their businesses were being helped — or hampered — by the latest trend. Drugs that mimic gut hormones such as glucagon-like peptide-1, or GLP-1, were…